Healthcare provider profile · identity verified

Timothy Sagers, MD

Family Practice · HIAWATHA, IA · NPI 1598725616

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	674	169
Levothyroxine Sodium	Levothyroxine Sodium	459	103
Losartan Potassium	Losartan Potassium	397	101
Amlodipine Besylate	Amlodipine Besylate	390	105
Omeprazole	Omeprazole	383	111
Lisinopril	Lisinopril	374	95
Simvastatin	Simvastatin	334	89
Metformin Hcl	Metformin Hcl	333	82
Tramadol Hcl	Tramadol Hcl	278	42
Irbesartan	Irbesartan	258	62
Pravastatin Sodium	Pravastatin Sodium	229	62
Hydrochlorothiazide	Hydrochlorothiazide	221	56
Pantoprazole Sodium	Pantoprazole Sodium	198	46
Metoprolol Succinate	Metoprolol Succinate	196	47
Alendronate Sodium	Alendronate Sodium	181	47
Trazodone Hcl	Trazodone Hcl	173	35
Gabapentin	Gabapentin	153	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	143	25
Citalopram Hbr	Citalopram Hydrobromide	136	36
Lorazepam	Lorazepam	136	27
Meloxicam	Meloxicam	131	33
Fluoxetine Hcl	Fluoxetine Hcl	128	34
Escitalopram Oxalate	Escitalopram Oxalate	120	30
Furosemide	Furosemide	115	28
Prednisone	Prednisone	111	88
Fenofibrate	Fenofibrate,micronized	101	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	95	25
Potassium Chloride	Potassium Chloride	95	23
Allopurinol	Allopurinol	92	27
Albuterol Sulfate Hfa	Albuterol Sulfate	90	42
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	24
Alprazolam	Alprazolam	87	12
Rosuvastatin Calcium	Rosuvastatin Calcium	87	22
Metformin Hcl Er	Metformin Hcl	85	24
Eliquis	Apixaban	82	22
Sertraline Hcl	Sertraline Hcl	81	22
Clopidogrel	Clopidogrel Bisulfate	78	21
Lovastatin	Lovastatin	76	22
Warfarin Sodium	Warfarin Sodium	76	11
Tamsulosin Hcl	Tamsulosin Hcl	75	22
Metoprolol Tartrate	Metoprolol Tartrate	74	21
Glimepiride	Glimepiride	73	18
Olmesartan Medoxomil	Olmesartan Medoxomil	73	21
Fluticasone Propionate	Fluticasone Propionate	66	15
Atenolol	Atenolol	65	17
Bupropion Xl	Bupropion Hcl	64	17
Fenofibrate	Fenofibrate Nanocrystallized	62	12
Gemfibrozil	Gemfibrozil	59	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	14
Montelukast Sodium	Montelukast Sodium	56	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	55	suppressed
Jardiance	Empagliflozin	54	15
Triamcinolone Acetonide	Triamcinolone Acetonide	53	29
Ropinirole Hcl	Ropinirole Hcl	51	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	51	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	50	15
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Finasteride	Finasteride	46	11
Donepezil Hcl	Donepezil Hcl	45	suppressed
Enalapril Maleate	Enalapril Maleate	42	suppressed
Famotidine	Famotidine	41	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	suppressed
Chlorthalidone	Chlorthalidone	37	11
Ozempic	Semaglutide	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	37	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Spironolactone	Spironolactone	34	suppressed
Fenofibrate	Fenofibrate	33	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Novolog Flexpen	Insulin Aspart	28	suppressed
Cephalexin	Cephalexin	26	21
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Baclofen	Baclofen	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Pregabalin	Pregabalin	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Azithromycin	Azithromycin	22	20
Doxycycline Hyclate	Doxycycline Hyclate	22	21
Testosterone	Testosterone	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	21	suppressed
Glipizide	Glipizide	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Estradiol	Estradiol	19	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Nystatin	Nystatin	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Risedronate Sodium	Risedronate Sodium	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Atropine Sulfate	Atropine Sulfate	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Glyburide	Glyburide	13	suppressed
Indapamide	Indapamide	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Primidone	Primidone	12	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error